BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25083963)

  • 1. Yolk sac tumor in postmenopausal patients: pure or associated with adenocarcinoma, a rare phenomenon.
    Roma AA; Przybycin CG
    Int J Gynecol Pathol; 2014 Sep; 33(5):477-82. PubMed ID: 25083963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral ovarian mixed epithelial adenocarcinoma in a postmenopausal woman with unilateral ovarian yolk sac tumor component.
    Chen Q; Chen X
    Int J Clin Exp Pathol; 2014; 7(11):8259-65. PubMed ID: 25550883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
    Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
    Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian endometrioid carcinoma with yolk sac tumor component in a postmenopausal woman.
    Kabukcuoglu S; Arik D
    Eur J Gynaecol Oncol; 2016; 37(6):867-869. PubMed ID: 29943939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
    Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
    Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours.
    McNamee T; Damato S; McCluggage WG
    Histopathology; 2016 Nov; 69(5):739-751. PubMed ID: 27334714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
    Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
    Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
    Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
    Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary juxtaovarian yolk sac tumor concurrent with an ipsilateral ovarian mature teratoma in an adult woman: a rare association.
    Ma H; Yu J; Tang J; Wang M
    Int J Clin Exp Pathol; 2015; 8(1):1046-9. PubMed ID: 25755817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High grade serous carcinoma of the ovary with a yolk sac tumour component in a postmenopausal woman: report of an extremely rare phenomenon.
    Varia M; McCluggage WG; Oommen R
    J Clin Pathol; 2012 Sep; 65(9):853-4. PubMed ID: 22496516
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
    Hodgson A; Ghorab Z; Parra-Herran C
    Int J Gynecol Pathol; 2021 May; 40(3):296-300. PubMed ID: 32209818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ovarian endometrioid adenocarcinoma with yolk sac tumor in a 35-year-old woman.
    Hong DG; Chong GO; Seong WJ; Lee YS; Cho YL; Park JY; Chae JM; Park IS
    Eur J Gynaecol Oncol; 2010; 31(4):471-4. PubMed ID: 20882900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
    Ulbright TM
    Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
    Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALL4 is a useful marker for pediatric yolk sac tumors.
    Wu P; Luo R; Sun B; Zhao J; Xu Q; Feng S; Chen X; Wang C
    Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
    Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
    Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
    Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
    Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.